Abstract:Background
Adalimumab, an anti-TNF-α monoclonal antibody, is effective in active rheumatoid arthritis (RA). Subcutaneous injections of adalimumab lead to highly variable trough concentrations between patients [1] that may partly explain the variability of response. To date, adalimumab pharmacokinetics (PK) after subcutaneous route has never been described.
Objectives
The goal of this study is to analyse the quantitative influence of individual factors on adalimumab PK in RA patients.
Methods
One hundred an… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.